Cancer-related anaemia
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 6
Abstract
Cancer-related anaemia occurs during the underlying malignancy in 40-75 percent of the patients. It has the influence on the quality of life, which can be significantly reduced and on the results of the planned and undergoing treatment. The mild anaemia can negatively impact the therapeutic treatment. Anaemia is often exacerbated by cancer treatment- -chemotherapy and radiotherapy. The blood transfusions or erythropoietin therapy help to equalize the decreased level of haemoglobin. Particular attention must be paid to the patients who received myelosuppressive treatment, radiation (in the pelvis minor area) and in cases when after the first course of chemotherapy the level of haemoglobin decreased by 2 g/dl. Numerous clinical studies have shown that erythropoietin can be an effective treatment in cancer-related anaemia.
Authors and Affiliations
Krzysztof Gawrychowski
Keywords
Related Articles
- EP ID EP154626
- DOI -
- Views 60
- Downloads 0
Ocena toksyczności stosowania g-csf w trakcie chemioradioterapii raka płuca
Wstęp: Stosowanie białokrwinkowych czynników wzrostu (g-csf, gm-csf) jest rekomendowane u chorych otrzymujących chemioterapię, u których dochodzi do neutropenii z gorączką neutropeniczną lub profilaktycznie w przypadku w...
A novel germ-line mutation in p53 gene
Germline mutations of p53 gene are rare, worldwide there are reported about 283 of such changes. They are strongly connected with Li-Fraumeni and Li-Fraumeni Like syndromes. They also may appear in multicancer syndrome....
Radiacyjna modyfikacja polietylenowych implantów chirurgicznych
Autorzy na przykładzie radiacyjnego sieciowania polietylenu omawiają zagadnienie modyfikacji polimerowych implantów chirurgicznych za pomocą promieniowania jonizującego. Zwracają uwagę na możliwość korzystnej modyfikacji...
The role of allogeneic hematopoietic stem transplantation in the treatment of solid tumors
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has become an established therapeutic approach for many hematological malignancies. Early attempts in transplantation usually used the myeloablative methodol...
The prognostic value of cytokine levels in patients with cancer
We have demonstrated that the serum levels of many cytokines and soluble cytokine receptors are increased in a great proportion of patients with ovarian cancer, colorectal cancer, non-small cell lung carcinoma and soft t...